UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 72 filers reported holding UROGEN PHARMA LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -8.3% | 1,282 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -45.5% | 1,282 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | +10.0% | 1,282 | 0.0% | 0.00% | – |
| Q2 2021 | $20,000 | -20.0% | 1,282 | 0.0% | 0.00% | – |
| Q1 2021 | $25,000 | +8.7% | 1,282 | 0.0% | 0.00% | – |
| Q4 2020 | $23,000 | -8.0% | 1,282 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | -24.2% | 1,282 | 0.0% | 0.00% | – |
| Q2 2020 | $33,000 | +43.5% | 1,282 | 0.0% | 0.00% | – |
| Q1 2020 | $23,000 | -46.5% | 1,282 | 0.0% | 0.00% | – |
| Q4 2019 | $43,000 | -25.9% | 1,282 | -47.0% | 0.00% | – |
| Q3 2019 | $58,000 | -33.3% | 2,421 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $87,000 | -2.2% | 2,421 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $89,000 | +81.6% | 2,421 | +112.6% | 0.00% | – |
| Q4 2018 | $49,000 | -9.3% | 1,139 | 0.0% | 0.00% | – |
| Q3 2018 | $54,000 | -5.3% | 1,139 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $57,000 | – | 1,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,155,862 | $38,571,000 | 11.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 849,478 | $28,347,000 | 4.49% |
| Horton Capital Management, LLC | 108,670 | $3,626,000 | 3.53% |
| Prosight Management, LP | 217,686 | $7,264,000 | 3.19% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $98,598,000 | 2.35% |
| Phoenix Holdings Ltd. | 834,739 | $27,663,000 | 1.16% |
| SHIKIAR ASSET MANAGEMENT INC | 67,025 | $2,237,000 | 0.74% |
| MEITAV INVESTMENT HOUSE LTD | 272,063 | $9,080,000 | 0.66% |
| Clal Insurance Enterprises Holdings Ltd | 17,666 | $529,388,000 | 0.57% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $24,637,000 | 0.48% |